Myb overexpression overrides androgen depletion-induced cell cycle arrest and apoptosis in prostate cancer cells, and confers aggressive malignant traits: Potential role in castration resistance

Carcinogenesis

Volumn 33, Issue 6, 2012, Pages 1149-1157

  Srivastava, Sanjeev K ^a   Bhardwaj, Arun ^a   Singh, Seema ^a   Arora, Sumit ^a   Mcclellan, Steven ^a   Grizzle, William E ^b   Reed, Eddie ^a   Singh, Ajay P ^a  

^a UNIVERSITY OF SOUTH ALABAMA   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CELL MARKER; CYCLIN A1; CYCLIN D1; CYCLIN E1; PROSTATE SPECIFIC ANTIGEN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN MYB; PROTEIN P27; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ANDROGEN DEPRIVATION THERAPY; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER RESISTANCE; CASTRATION RESISTANT PROSTATE CANCER; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL GROWTH; CELL INVASION; CELL LINEAGE; CELL LOSS; CELL MOTILITY; CELL STRAIN LNCAP; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FILOPODIUM; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; LOSS OF FUNCTION MUTATION; MALE; MALIGNANT TRANSFORMATION; MESENCHYME CELL; ONCOGENE MYB; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN DEPLETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; UPREGULATION; WESTERN BLOTTING;

ANDROGENS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-ASSOCIATED DEATH PROTEIN; BCL-X PROTEIN; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CYCLIN A1; CYCLIN D1; CYCLIN E; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; MALE; NEOPLASM INVASIVENESS; ONCOGENE PROTEINS; ONCOGENE PROTEINS V-MYB; ORCHIECTOMY; PROLIFERATING CELL NUCLEAR ANTIGEN; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PSEUDOPODIA; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 84864309906     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs134     Document Type: Article

References (50)

1. Jemal,A. et al. (2010) Cancer statistics, 2010. CA Cancer J.Clin., 60, 277-300.
2. Feldman,B.J. et al. (2001) The development of androgen-independent prostate cancer. Nat. Rev. Cancer., 1, 34-45.
3. Attard,G. et al. (2009) Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer. Cancer Res., 69, 2912-2918.
4. Chen,T. et al. (2000) Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells. Cancer Res., 60, 2132-2135.
5. Culig,Z. et al. (1993) Mutant androgen receptor detected in an advancedstage prostatic carcinoma is activated by adrenal androgens and progesterone. Mol.Endocrinol., 7, 1541-1550.
6. Hobisch,A. et al. (1998) Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor. Cancer Res., 58, 4640-4645.
7. Schroder,F.H. (2008) Progress in understanding androgen-independent prostate cancer (AIPC): a review of potential endocrine-mediated mechanisms. Eur. Urol., 53, 1129-1137.
8. Edwards,J. et al. (2003) Gene amplifications associated with the development of hormone-resistant prostate cancer. Clin. Cancer Res., 9, 5271- 5281.
9. Ramsay,R.G. et al. (2008) MYB function in normal and cancer cells. Nat. Rev. Cancer., 8, 523-534.
10. Kanei-Ishii,C. et al. (1994) c-Myb-induced trans-activation mediated by heat shock elements without sequence-specific DNA binding of c-Myb. J. Biol. Chem., 269, 15768-15775.
11. Gonda,T.J. et al. (1984) Expression of myb, myc and fos proto-oncogenes during the differentiation of a murine myeloid leukaemia. Nature., 310, 249-251.
12. Kauraniemi,P. et al. (2000) MYB oncogene amplification in hereditary BRCA1 breast cancer. Cancer Res., 60, 5323-5328.
13. Melani,C. et al. (1991) Inhibition of proliferation by c-myb antisense oligodeoxynucleotides in colon adenocarcinoma cell lines that express c-myb. Cancer Res., 51, 2897-2901.
14. Park,J.G. et al. (1992) Large-scale molecular mapping of human c-myb locus: c-myb proto-oncogene is not involved in 6q- abnormalities of lymphoid tumors. Oncogene., 7, 1603-1609.
15. Torelli,G. et al. (1987) Expression of c-myb protooncogene and other cell cycle-related genes in normal and neoplastic human colonic mucosa. Cancer Res., 47, 5266-5269.
16. Zorbas,M. et al. (1999) c-Myb is critical for murine colon development. Oncogene., 18, 5821-5830.
17. Mucenski,M.L. et al. (1991) A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell., 65, 677-689.
18. Hess,J.L. et al. (2006) c-Myb is an essential downstream target for homeobox-mediated transformation of hematopoietic cells. Blood., 108, 297-304.
19. Calabretta,B. et al. (1991) Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides: an in vitro study relevant to bone marrow purging. Proc. Natl. Acad. Sci. USA., 88, 2351-2355.
20. Lidonnici,M.R. et al. (2008) Requirement of c-Myb for p.210(BCR/ABL)-dependent transformation of hematopoietic progenitors and leukemogenesis. Blood., 111, 4771-4779.
21. Hijiya,N. et al. (1994) Biologic and therapeutic significance of MYB expression in human melanoma. Proc. Natl. Acad. Sci. USA., 91, 4499- 4503.
22. Persson,M. et al. (2009) Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc. Natl. Acad. Sci. USA., 106, 18740-18744.
23. Thompson,M.A. et al. (1998) c-Myb down-regulation is associated with human colon cell differentiation, apoptosis, and decreased Bcl-2 expression. Cancer Res., 58, 5168-5175.
24. Singh,S. et al. (2010) CXCL12-CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapy. Br. J. Cancer., 103, 1671-1679.
25. Singh,A.P. et al. (2004) Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis. Cancer Res., 64, 622-630.
26. Stamey,T.A. et al. (1989) Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. IV. Anti-androgen treated patients. J. Urol., 141, 1088-1090.
27. Cheng,H. et al. (2006) Short hairpin RNA knockdown of the androgen receptor attenuates ligand-independent activation and delays tumor progression. Cancer Res., 66, 10613-10620.
28. Ellis,W.J. et al. (1996) Characterization of a novel androgen-sensitive, prostate-specific antigen-producing prostatic carcinoma xenograft: LuCaP Clin. Cancer Res., 2, 1039-1048.
29. Bhardwaj,A. et al. (2011) Modulation of protein phosphatase 2A (PP2A) activity alters androgen-independent growth of prostate cancer cells: therapeutic implications. Mol. Cancer Ther., 10, 720-731.
30. Jennbacken,K. et al. (2006) Prostate cancer progression into androgen independency is associated with alterations in cell adhesion and invasivity. Prostate., 66, 1631-1640.
31. Singh,A. et al. (2010) EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene., 29, 4741-4751.
32. Shankar,J. et al. (2010) Pseudopodial actin dynamics control epithelialmesenchymal transition in metastatic cancer cells. Cancer Res., 70, 3780-3790.
33. Locke,J.A. et al. (2008) Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer. Cancer Res., 68, 6407-6415.
34. Sun,D. et al. (2011) miR-99 family of MicroRNAs suppresses the expression of prostate-specific antigen and prostate cancer cell proliferation. Cancer Res., 71, 1313-1324.
35. Yeung,F. et al. (2000) Regions of prostate-specific antigen (PSA) promoter confer androgen-independent expression of PSA in prostate cancer cells. J. Biol. Chem., 275, 40846-40855.
36. Hernandez-Munain,C. et al. (1995) c-Myb and core-binding factor/PEBP2 display functional synergy but bind independently to adjacent sites in the T-cell receptor delta enhancer. Mol. Cell Biol., 15, 3090-3099.
37. Oelgeschlager,M. et al. (1996) C/EBP, c-Myb, and PU.1 cooperate to regulate the neutrophil elastase promoter. Mol. Cell Biol., 16, 4717-4725.
38. Shapiro,L.H. (1995) Myb and Ets proteins cooperate to transactivate an early myeloid gene. J. Biol. Chem., 270, 8763-8771.
39. Knudsen,K.E. et al. (1998) Multiple G1 regulatory elements control the androgen-dependent proliferation of prostatic carcinoma cells. J. Biol. Chem., 273, 20213-20222.
40. Eto,M. et al. (2003) C16 ceramide accumulates following androgen ablation in LNCaP prostate cancer cells. Prostate., 57, 66-79.
41. Muller,C. et al. (1999) c-myb transactivates the human cyclin A1 promoter and induces cyclin A1 gene expression. Blood., 94, 4255-4262.
42. Malaterre,J. et al. (2007) c-Myb is required for progenitor cell homeostasis in colonic crypts. Proc. Natl. Acad. Sci. USA., 104, 3829-3834.
43. Biroccio,A. et al. (2001) c-Myb and Bcl-x overexpression predicts poor prognosis in colorectal cancer: clinical and experimental findings. Am. J. Pathol., 158, 1289-1299.
44. Yuan,J. et al. (2010) c-Myb promotes the survival of CD4{thorn}CD8{thorn} doublepositive thymocytes through upregulation of Bcl-xL. J. Immunol., 184, 2793-2804.
45. Salomoni,P. et al. (1997) Resistance to apoptosis in CTLL-2 cells constitutively expressing c-Myb is associated with induction of BCL-2 expression and Myb-dependent regulation of bcl-2 promoter activity. Proc. Natl. Acad. Sci. USA., 94, 3296-3301.
46. Wilkins,H.R. et al. (2010) Estrogen prevents sustained COLO-205 human colon cancer cell growth by inducing apoptosis, decreasing c-myb protein, and decreasing transcription of the anti-apoptotic protein bcl-2. Tumour. Biol., 31, 16-22.
47. Pitsch,R.J. et al. (1996) Inhibition of smooth muscle cell proliferation and migration in vitro by antisense oligonucleotide to c-myb. J. Vasc. Surg., 23, 783-791.
48. Chen,R.X. et al. (2010) Transcription factor c-Myb promotes the invasion of hepatocellular carcinoma cells via increasing osteopontin expression. J. Exp. Clin. Cancer Res., 29, 172.
49. Tanno,B. et al. (2010) Expression of Slug is regulated by c-Myb and is required for invasion and bone marrow homing of cancer cells of different origin. J. Biol. Chem., 285, 29434-29445.
50. Karafiat,V. et al. (2005) Transcription factor c-Myb is involved in the regulation of the epithelial-mesenchymal transition in the avian neural crest. Cell Mol. Life Sci., 62, 2516-2525.